Clinical Utilization Pattern of Multiple Strengths of Glimepiride and Metformin Fixed Dose Combinations in Indian Type 2 Diabetes Patients.

格列美脲 医学 二甲双胍 糖尿病 2型糖尿病 磺酰脲 体质指数 内科学 内分泌学
作者
Unnikrishnan Ag,Kaushik Pandit,Jesso George,Satchi Venkataraman,Abhyankar Mv
出处
期刊:PubMed [National Institutes of Health]
卷期号:68 (7): 57-61 被引量:6
链接
标识
摘要

In Indian clinical set-up, modern sulfonylurea, particularly glimepiride is still preferred as an add-on to metformin due to its efficacy, safety and cost effectiveness. In view of this, a case-based questionnaire survey was conducted to analyze the clinical utility of multiple strengths of glimepiride and metformin fixed dose combination in type 2 diabetes mellitus (T2DM).The case-based questionnaire survey was conducted with 174 health care professionals across India to assess the use of glimepiride and metformin fixed dose combination according to age, duration of diabetes, body mass index (BMI), diabetes complications, concomitant medications like insulin, and statin.Overall, data from 2248 patients taking multiple strengths of glimepiride and metformin fixed dose combination were analyzed. All the doses were prescribed across all the age groups and irrespective of duration of diabetes. Overall, 1429 diabetes patients had body mass index (BMI) ≥25 kg/m2, among which 1176 (81.6%) patients were receiving combination of glimepiride 1 or 2 mg and metformin 500 or 850 or 1000 mg. Glimepiride and metformin fixed dose combinations were among the preferred choices in various complications like neuropathy, retinopathy, nephropathy, peripheral vascular disease, diabetic foot and cardiovascular disease. Insulin and statins were co-prescribed in 17.3% and 28.8% patients, respectively. Hypoglycemic episodes were reported in only a minority of patients, even with higher doses of glimepiride and metformin fixed dose combinations.Multiple strengths of glimepiride and metformin fixed dose combinations are beneficial in T2DM, irrespective of age, duration of diabetes, BMI, diabetes complications, use of concomitant medications such as insulin and statin. Glimepiride and metformin fixed dose combinations were not associated with a significant risk of hypoglycemia.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Charlie发布了新的文献求助10
1秒前
zzz2193发布了新的文献求助10
1秒前
1秒前
2秒前
研友_Lw4Ngn发布了新的文献求助10
2秒前
yan完成签到,获得积分10
2秒前
Lucas的应助被Viper采纳,获得10
2秒前
3秒前
星辰大海的应助被lcj1014采纳,获得10
3秒前
3秒前
3秒前
3秒前
雄壮的小妞完成签到,获得积分10
4秒前
4秒前
Jade完成签到,获得积分10
4秒前
核桃发布了新的文献求助10
5秒前
噜啦啦完成签到,获得积分10
5秒前
一一完成签到 ,获得积分10
5秒前
llzuo发布了新的文献求助10
5秒前
5秒前
夕犬水完成签到,获得积分10
5秒前
guest发布了新的文献求助10
5秒前
5秒前
糊涂的万发布了新的文献求助10
6秒前
英俊的铭的应助被万慕木采纳,获得10
7秒前
superZ发布了新的文献求助10
7秒前
cmh发布了新的文献求助10
7秒前
7秒前
聪明的芝完成签到,获得积分20
8秒前
秋风的应助被吐司采纳,获得10
8秒前
chi发布了新的文献求助10
8秒前
田様的应助被粗犷的天佑采纳,获得10
9秒前
自信依白发布了新的文献求助20
9秒前
9秒前
JamesPei的应助被策略采纳,获得10
10秒前
10秒前
刘海青完成签到,获得积分10
10秒前
10秒前
sui发布了新的文献求助30
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178048
求助须知:如何正确求助?哪些是违规求助? 9568764
关于积分的说明 21801331
捐赠科研通 7772794
什么是DOI,文献DOI怎么找? 3432613
关于科研通互助平台的介绍 2556748
邀请新用户注册赠送积分活动 2478151